Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice
Idiopathic steroid sensitive nephrotic syndrome (INS), the most frequent childhood nephropathy, is thought to be mediated by a circulating soluble factor that reversibly affects the renal protein sieving. The efficiency of rituximab therapy recently highlighted the involvement of B cells. Here we st...
Saved in:
Published in | Journal of autoimmunity Vol. 89; pp. 149 - 161 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.05.2018
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 0896-8411 1095-9157 1095-9157 |
DOI | 10.1016/j.jaut.2017.12.014 |
Cover
Abstract | Idiopathic steroid sensitive nephrotic syndrome (INS), the most frequent childhood nephropathy, is thought to be mediated by a circulating soluble factor that reversibly affects the renal protein sieving. The efficiency of rituximab therapy recently highlighted the involvement of B cells. Here we studied the involvement of a specific immunoglobulin G (IgG) in the disease. After plasma fractionation by size exclusion chromatography, a detachment of cultured podocyte was observed with one IgG-containing fraction from 47% patients in relapse, 9% of patients in remission and 0% of controls. Podocyte protein lysates were immunoprecipitated by IgG from those plasma fractions identifying a list of 41 podocyte proteins after proteomic analysis. Five podocyte targets were selected on statistical and biological criteria. Specific antibodies were tested and only anti-Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) IgG led to podocyte detachment. UCHL1 was mainly found inside the podocyte but also weakly expressed on podocyte cell surface. Incubation of either anti-UCHL1 IgG or plasma fractions with recombinant UCHL1 prevented podocyte detachment. Plasma levels of anti-UCHL1 IgG were significantly increased in relapsing INS patients compared to patients in remission and controls. Proteinuria correlated with anti-UCHL1 IgG level at various stages of the disease. Purified patient anti-UCHL1 antibodies induced proteinuria and podocyte foot effacement in mice. Altogether, these results identified UCHL1 as a target podocyte protein of autoantibodies in a set of relapsing patients and support a causative role of anti-UCHL1 autoantibodies in the development of INS.
•Idiopathic nephrotic syndrome: not a kidney disease but a primary B cell disease.•Anti-UCHL1 IgG Abs lead to a detachment of cultured podocytes.•Plasma anti-UCHL1 IgG Abs are increased in a subgroup of INS patients with proteinuria.•Anti-UCHL1 IgG Abs induce proteinuria and foot process effacement in mice. |
---|---|
AbstractList | Idiopathic steroid sensitive nephrotic syndrome (INS), the most frequent childhood nephropathy, is thought to be mediated by a circulating soluble factor that reversibly affects the renal protein sieving. The efficiency of rituximab therapy recently highlighted the involvement of B cells. Here we studied the involvement of a specific immunoglobulin G (IgG) in the disease. After plasma fractionation by size exclusion chromatography, a detachment of cultured podocyte was observed with one IgG-containing fraction from 47% patients in relapse, 9% of patients in remission and 0% of controls. Podocyte protein lysates were immunoprecipitated by IgG from those plasma fractions identifying a list of 41 podocyte proteins after proteomic analysis. Five podocyte targets were selected on statistical and biological criteria. Specific antibodies were tested and only anti-Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) IgG led to podocyte detachment. UCHL1 was mainly found inside the podocyte but also weakly expressed on podocyte cell surface. Incubation of either anti-UCHL1 IgG or plasma fractions with recombinant UCHL1 prevented podocyte detachment. Plasma levels of anti-UCHL1 IgG were significantly increased in relapsing INS patients compared to patients in remission and controls. Proteinuria correlated with anti-UCHL1 IgG level at various stages of the disease. Purified patient anti-UCHL1 antibodies induced proteinuria and podocyte foot effacement in mice. Altogether, these results identified UCHL1 as a target podocyte protein of autoantibodies in a set of relapsing patients and support a causative role of anti-UCHL1 autoantibodies in the development of INS.
•Idiopathic nephrotic syndrome: not a kidney disease but a primary B cell disease.•Anti-UCHL1 IgG Abs lead to a detachment of cultured podocytes.•Plasma anti-UCHL1 IgG Abs are increased in a subgroup of INS patients with proteinuria.•Anti-UCHL1 IgG Abs induce proteinuria and foot process effacement in mice. Idiopathic steroid sensitive nephrotic syndrome (INS), the most frequent childhood nephropathy, is thought to be mediated by a circulating soluble factor that reversibly affects the renal protein sieving. The efficiency of rituximab therapy recently highlighted the involvement of B cells. Here we studied the involvement of a specific immunoglobulin G (IgG) in the disease. After plasma fractionation by size exclusion chromatography, a detachment of cultured podocyte was observed with one IgG-containing fraction from 47% patients in relapse, 9% of patients in remission and 0% of controls. Podocyte protein lysates were immunoprecipitated by IgG from those plasma fractions identifying a list of 41 podocyte proteins after proteomic analysis. Five podocyte targets were selected on statistical and biological criteria. Specific antibodies were tested and only anti-Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) IgG led to podocyte detachment. UCHL1 was mainly found inside the podocyte but also weakly expressed on podocyte cell surface. Incubation of either anti-UCHL1 IgG or plasma fractions with recombinant UCHL1 prevented podocyte detachment. Plasma levels of anti-UCHL1 IgG were significantly increased in relapsing INS patients compared to patients in remission and controls. Proteinuria correlated with anti-UCHL1 IgG level at various stages of the disease. Purified patient anti-UCHL1 antibodies induced proteinuria and podocyte foot effacement in mice. Altogether, these results identified UCHL1 as a target podocyte protein of autoantibodies in a set of relapsing patients and support a causative role of anti-UCHL1 autoantibodies in the development of INS. Idiopathic steroid sensitive nephrotic syndrome (INS), the most frequent childhood nephropathy, is thought to be mediated by a circulating soluble factor that reversibly affects the renal protein sieving. The efficiency of rituximab therapy recently highlighted the involvement of B cells. Here we studied the involvement of a specific immunoglobulin G (IgG) in the disease. After plasma fractionation by size exclusion chromatography, a detachment of cultured podocyte was observed with one IgG-containing fraction from 47% patients in relapse, 9% of patients in remission and 0% of controls. Podocyte protein lysates were immunoprecipitated by IgG from those plasma fractions identifying a list of 41 podocyte proteins after proteomic analysis. Five podocyte targets were selected on statistical and biological criteria. Specific antibodies were tested and only anti-Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) IgG led to podocyte detachment. UCHL1 was mainly found inside the podocyte but also weakly expressed on podocyte cell surface. Incubation of either anti-UCHL1 IgG or plasma fractions with recombinant UCHL1 prevented podocyte detachment. Plasma levels of anti-UCHL1 IgG were significantly increased in relapsing INS patients compared to patients in remission and controls. Proteinuria correlated with anti-UCHL1 IgG level at various stages of the disease. Purified patient anti-UCHL1 antibodies induced proteinuria and podocyte foot effacement in mice. Altogether, these results identified UCHL1 as a target podocyte protein of autoantibodies in a set of relapsing patients and support a causative role of anti-UCHL1 autoantibodies in the development of INS.Idiopathic steroid sensitive nephrotic syndrome (INS), the most frequent childhood nephropathy, is thought to be mediated by a circulating soluble factor that reversibly affects the renal protein sieving. The efficiency of rituximab therapy recently highlighted the involvement of B cells. Here we studied the involvement of a specific immunoglobulin G (IgG) in the disease. After plasma fractionation by size exclusion chromatography, a detachment of cultured podocyte was observed with one IgG-containing fraction from 47% patients in relapse, 9% of patients in remission and 0% of controls. Podocyte protein lysates were immunoprecipitated by IgG from those plasma fractions identifying a list of 41 podocyte proteins after proteomic analysis. Five podocyte targets were selected on statistical and biological criteria. Specific antibodies were tested and only anti-Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) IgG led to podocyte detachment. UCHL1 was mainly found inside the podocyte but also weakly expressed on podocyte cell surface. Incubation of either anti-UCHL1 IgG or plasma fractions with recombinant UCHL1 prevented podocyte detachment. Plasma levels of anti-UCHL1 IgG were significantly increased in relapsing INS patients compared to patients in remission and controls. Proteinuria correlated with anti-UCHL1 IgG level at various stages of the disease. Purified patient anti-UCHL1 antibodies induced proteinuria and podocyte foot effacement in mice. Altogether, these results identified UCHL1 as a target podocyte protein of autoantibodies in a set of relapsing patients and support a causative role of anti-UCHL1 autoantibodies in the development of INS. |
Author | Chemouny, Jonathan M. Berthelot, Laureline Dehoux, Laurène Daugas, Eric Boedec, Erwan Dossier, Claire Deschênes, Georges Abbad, Lilia Monteiro, Renato C. Couderc, Anne Jamin, Agnès |
Author_xml | – sequence: 1 givenname: Agnès surname: Jamin fullname: Jamin, Agnès organization: National French Institute of Health and Medical Research (INSERM) 1149, Center of Research on Inflammation, Paris, France – sequence: 2 givenname: Laureline surname: Berthelot fullname: Berthelot, Laureline organization: National French Institute of Health and Medical Research (INSERM) 1149, Center of Research on Inflammation, Paris, France – sequence: 3 givenname: Anne orcidid: 0000-0001-5357-4671 surname: Couderc fullname: Couderc, Anne organization: Paris Diderot University, Sorbonne Paris Cité, Paris, France – sequence: 4 givenname: Jonathan M. orcidid: 0000-0001-6309-3986 surname: Chemouny fullname: Chemouny, Jonathan M. organization: Paris Diderot University, Sorbonne Paris Cité, Paris, France – sequence: 5 givenname: Erwan surname: Boedec fullname: Boedec, Erwan organization: National French Institute of Health and Medical Research (INSERM) 1149, Center of Research on Inflammation, Paris, France – sequence: 6 givenname: Laurène surname: Dehoux fullname: Dehoux, Laurène organization: Paris Diderot University, Sorbonne Paris Cité, Paris, France – sequence: 7 givenname: Lilia surname: Abbad fullname: Abbad, Lilia organization: National French Institute of Health and Medical Research (INSERM) 1149, Center of Research on Inflammation, Paris, France – sequence: 8 givenname: Claire surname: Dossier fullname: Dossier, Claire organization: Paris Diderot University, Sorbonne Paris Cité, Paris, France – sequence: 9 givenname: Eric orcidid: 0000-0001-7256-7979 surname: Daugas fullname: Daugas, Eric organization: Paris Diderot University, Sorbonne Paris Cité, Paris, France – sequence: 10 givenname: Renato C. surname: Monteiro fullname: Monteiro, Renato C. organization: National French Institute of Health and Medical Research (INSERM) 1149, Center of Research on Inflammation, Paris, France – sequence: 11 givenname: Georges surname: Deschênes fullname: Deschênes, Georges email: georges.deschenes@rdb.aphp.fr organization: Paris Diderot University, Sorbonne Paris Cité, Paris, France |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29307588$$D View this record in MEDLINE/PubMed https://univ-rennes.hal.science/hal-02445649$$DView record in HAL |
BookMark | eNqFkcFuEzEQhleoiKaFF-CA9giHBM9mHduISxS1BCkSF3q2HHtCJmzsxfYW5caj41VKDz2U00ij7_s1mv-quvDBY1W9BTYDBouPh9nBDHnWMBAzaGYM2hfVBJjiUwVcXFQTJtViKluAy-oqpQNjAJzzV9Vlo-ZMcCkn1Z_lkIPxmbbBEaba_DDkU6774II9ZbL13Wq9gdpErE1KwZLJ6OrflPc1OQq9yfsCeez3MYx4OnkXwxHriJ3p0xjpXU3eDRbrvjBIfohkyqo-ksXX1cud6RK-eZjX1d3tzffVerr59uXrarmZ2lbyPLWNBAlWzFXLrYK5sA0iCuUEd1KI7a48BNEuWgZKCcUBlGgb0WzRcLdDNb-uPpxz96bTfaSjiScdDOn1cqPHHWvali9adQ-FfX9my72_BkxZHylZ7DrjMQxJg5KKl0tkU9B3D-iwPaJ7TP734QI0Z8DGkFLE3SMCTI816oMea9RjjRoaXWosknwiWcomU_A5GuqeVz-fVSzPvCeMOllCb9FRRJu1C_S8_umJbjvyZE33E0__k_8CrFTMvA |
CitedBy_id | crossref_primary_10_1159_000533695 crossref_primary_10_1093_ndt_gfaa211 crossref_primary_10_3390_ijms25021303 crossref_primary_10_1016_S0140_6736_23_01051_6 crossref_primary_10_3389_fmed_2023_1189017 crossref_primary_10_3390_jcm8030298 crossref_primary_10_1007_s00467_023_06006_9 crossref_primary_10_1007_s00467_024_06447_w crossref_primary_10_1007_s00467_020_04811_0 crossref_primary_10_1007_s00467_021_05401_4 crossref_primary_10_1159_000543334 crossref_primary_10_1016_j_pedneo_2024_10_003 crossref_primary_10_1186_s12882_024_03485_2 crossref_primary_10_3389_fimmu_2023_1247606 crossref_primary_10_1093_ckj_sfaa276 crossref_primary_10_3389_fimmu_2022_823204 crossref_primary_10_1016_j_repbio_2020_03_010 crossref_primary_10_1007_s00431_021_04357_9 crossref_primary_10_1159_000540511 crossref_primary_10_1016_j_ekir_2024_01_005 crossref_primary_10_1681_ASN_0000000624 crossref_primary_10_2215_CJN_08570722 crossref_primary_10_1681_ASN_2021040561 crossref_primary_10_1007_s11255_023_03592_3 crossref_primary_10_3389_fimmu_2023_1335936 crossref_primary_10_1007_s00467_018_4133_x crossref_primary_10_1007_s12016_019_08745_w crossref_primary_10_1016_j_jep_2020_112789 crossref_primary_10_1007_s11560_023_00680_4 crossref_primary_10_1016_j_kint_2024_10_027 crossref_primary_10_1155_2021_6671552 crossref_primary_10_1007_s00441_019_03147_y crossref_primary_10_1038_s41467_023_37836_8 crossref_primary_10_1016_j_nefro_2022_11_004 crossref_primary_10_1093_ndt_gfaa279 crossref_primary_10_1155_2019_7304786 crossref_primary_10_1007_s00467_018_4095_z crossref_primary_10_1038_s41390_022_02336_w crossref_primary_10_1111_apa_14582 crossref_primary_10_1016_j_nefroe_2023_04_003 crossref_primary_10_3389_fimmu_2023_1167741 crossref_primary_10_3389_fneph_2024_1471078 crossref_primary_10_1007_s00467_021_05175_9 crossref_primary_10_1186_s12882_021_02437_4 crossref_primary_10_1681_ASN_2022080949 crossref_primary_10_1007_s10157_024_02508_4 crossref_primary_10_1016_j_autrev_2020_102671 crossref_primary_10_1681_ASN_0000000525 crossref_primary_10_1007_s00018_023_04747_2 crossref_primary_10_1053_j_akdh_2024_02_002 crossref_primary_10_1111_nep_14249 crossref_primary_10_3389_fimmu_2022_985925 crossref_primary_10_2215_CJN_07180622 crossref_primary_10_3390_ijms222212123 crossref_primary_10_3389_fmed_2021_761600 crossref_primary_10_1016_j_ekir_2021_04_029 crossref_primary_10_3389_fneph_2024_1480968 |
Cites_doi | 10.1097/00007890-200202150-00013 10.1681/ASN.2004030172 10.1111/j.1471-4159.1985.tb05461.x 10.1111/nep.12256 10.1056/NEJMcibr0806881 10.1038/nri2155 10.1038/labinvest.2008.125 10.1007/s00467-011-1830-0 10.1681/ASN.2014030247 10.1126/scitranslmed.3002231 10.1007/s00467-014-2860-1 10.1128/MCB.00730-13 10.1016/j.jprot.2013.01.012 10.1038/ki.2012.169 10.1681/ASN.V133630 10.1002/path.2511 10.1111/j.1365-2249.2005.02862.x 10.1002/path.2446 10.1016/j.pneurobio.2009.10.020 10.1016/S0272-6386(03)00346-9 10.1016/j.nmd.2014.03.012 10.1038/nm.1857 10.1016/S0022-3476(86)80876-9 10.1152/ajprenal.00161.2010 10.1681/ASN.2013101067 10.1016/S0140-6736(14)60541-9 10.1681/ASN.2015050523 10.1111/cei.12659 10.2215/CJN.05000516 |
ContentType | Journal Article |
Copyright | 2017 The Authors Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: 2017 The Authors – notice: Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC |
DOI | 10.1016/j.jaut.2017.12.014 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1095-9157 |
EndPage | 161 |
ExternalDocumentID | oai_HAL_hal_02445649v1 29307588 10_1016_j_jaut_2017_12_014 S0896841117306844 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29J 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AAAJQ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFRF ABJNI ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG CJTIS COF CS3 DM4 DU5 EBS EFBJH EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDU HMG HMK HMO HVGLF HZ~ IHE J1W KOM LG5 LUGTX LZ5 M29 M41 MO0 N9A O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SES SEW SIN SPCBC SSH SSI SSZ T5K WUQ XPP Z5R ZGI ZMT ZU3 ~G- 6I. AACTN AAFTH AAIAV ABLVK ABYKQ AFCTW AFKWA AJBFU AJOXV AMFUW EFLBG LCYCR RIG AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 ACLOT ~HD 1XC |
ID | FETCH-LOGICAL-c485t-c28181c73945c9137c2eee79d75d877bf016eec64019979511974272bea5dfe93 |
IEDL.DBID | AIKHN |
ISSN | 0896-8411 1095-9157 |
IngestDate | Fri Sep 12 12:49:24 EDT 2025 Sun Sep 28 03:22:26 EDT 2025 Mon Jul 21 05:45:02 EDT 2025 Tue Jul 01 03:24:08 EDT 2025 Thu Apr 24 22:50:11 EDT 2025 Fri Feb 23 02:29:34 EST 2024 Tue Aug 26 18:14:46 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Foot process effacement Immunoglobulin Pediatric nephrology Proteinuria |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c485t-c28181c73945c9137c2eee79d75d877bf016eec64019979511974272bea5dfe93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-5357-4671 0000-0001-6309-3986 0000-0001-7256-7979 0000-0002-9306-9247 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0896841117306844 |
PMID | 29307588 |
PQID | 1989539482 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | hal_primary_oai_HAL_hal_02445649v1 proquest_miscellaneous_1989539482 pubmed_primary_29307588 crossref_primary_10_1016_j_jaut_2017_12_014 crossref_citationtrail_10_1016_j_jaut_2017_12_014 elsevier_sciencedirect_doi_10_1016_j_jaut_2017_12_014 elsevier_clinicalkey_doi_10_1016_j_jaut_2017_12_014 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 2018 2018-05-00 20180501 2018-05 |
PublicationDateYYYYMMDD | 2018-05-01 |
PublicationDate_xml | – month: 05 year: 2018 text: May 2018 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of autoimmunity |
PublicationTitleAlternate | J Autoimmun |
PublicationYear | 2018 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Fornoni, Sageshima, Wei, Merscher-Gomez, Aguillon-Prada, Jauregui (bib15) 2011; 3 Day, Thompson (bib18) 2010; 90 Coward, Foster, Patton, Ni, Lennon, Bates (bib9) 2005; 16 Guess, Agrawal, Wei, Ransom, Benndorf, Smoyer (bib13) 2010; 299 Saleem, O'Hare, Reiser, Coward, Inward, Farren (bib10) 2002; 13 Bradbury, Thompson (bib19) 1985; 44 Liu, Wu, Wu, Wang, Gan, Zhang (bib21) 2009; 217 Rouillon, Zocevic, Leger, Garcia, Camadro, Udd (bib11) 2014; 24 Yu, Suleiman, Kim, Miner, Dani, Shaw (bib25) 2013; 33 Schwartz, Schneider, Maier, Moxey-Mims, Dharnidharka, Warady (bib32) 2012; 82 Prunotto, Farina, Lane, Pernin, Schifferli, Hochstrasser (bib22) 2013; 82 Roopenian, Akilesh (bib30) 2007; 7 Hiraoka, Tsukahara, Matsubara, Tsurusawa, Takeda, Haruki (bib4) 2003; 41 Zhou, Li, He, Zhou, Tan, Nie (bib26) 2015; 26 Iijima, Sako, Nozu, Mori, Tuchida, Kamei (bib7) 2014; 384 Vivarelli, Massella, Ruggiero, Emma (bib1) 2017; 12 Meyer-Schwesinger, Meyer, Munster, Klug, Saleem, Helmchen (bib20) 2009; 217 Shimizu, Khoshnoodi, Akimoto, Kawakami, Hirano, Higashihara (bib31) 2009; 89 Gbadegesin, Adeyemo, Webb, Greenbaum, Abeyagunawardena, Thalgahagoda (bib5) 2015; 26 Azib, Macher, Kwon, Dechartres, Alberti, Loirat (bib6) 2011; 26 Colucci, Carsetti, Cascioli, Casiraghi, Perna, Rava (bib8) 2016; 27 Radon, Czesla, Reichelt, Fehlert, Hammel, Rosendahl (bib23) 2017 Musante, Candiano, Bruschi, Santucci, Carnemolla, Orecchia (bib16) 2005; 141 Patrakka, Ruotsalainen, Reponen, Qvist, Laine, Holmberg (bib17) 2002; 73 Jamin, Dehoux, Dossier, Fila, Heming, Monteiro (bib28) 2015; 182 Mathieson (bib3) 2008; 359 Hodson, Wong, Willis, Craig (bib12) 2016; 10 Sun, Zhang, Hu, Sun, Mao, Zhao (bib24) 2014; 9 MacDonald, Wolfish, McLaine, Phipps, Rossier (bib29) 1986; 108 Liu, Zhang, Wang, Liu (bib2) 2014; 19 Faul, Donnelly, Merscher-Gomez, Chang, Franz, Delfgaauw (bib14) 2008; 14 Dossier, Sellier-Leclerc, Rousseau, Michel, Gautheret-Dejean, Englender (bib27) 2014; 29 Meyer-Schwesinger (10.1016/j.jaut.2017.12.014_bib20) 2009; 217 Saleem (10.1016/j.jaut.2017.12.014_bib10) 2002; 13 Dossier (10.1016/j.jaut.2017.12.014_bib27) 2014; 29 Vivarelli (10.1016/j.jaut.2017.12.014_bib1) 2017; 12 MacDonald (10.1016/j.jaut.2017.12.014_bib29) 1986; 108 Gbadegesin (10.1016/j.jaut.2017.12.014_bib5) 2015; 26 Hiraoka (10.1016/j.jaut.2017.12.014_bib4) 2003; 41 Liu (10.1016/j.jaut.2017.12.014_bib21) 2009; 217 Guess (10.1016/j.jaut.2017.12.014_bib13) 2010; 299 Day (10.1016/j.jaut.2017.12.014_bib18) 2010; 90 Bradbury (10.1016/j.jaut.2017.12.014_bib19) 1985; 44 Hodson (10.1016/j.jaut.2017.12.014_bib12) 2016; 10 Faul (10.1016/j.jaut.2017.12.014_bib14) 2008; 14 Fornoni (10.1016/j.jaut.2017.12.014_bib15) 2011; 3 Shimizu (10.1016/j.jaut.2017.12.014_bib31) 2009; 89 Mathieson (10.1016/j.jaut.2017.12.014_bib3) 2008; 359 Yu (10.1016/j.jaut.2017.12.014_bib25) 2013; 33 Coward (10.1016/j.jaut.2017.12.014_bib9) 2005; 16 Sun (10.1016/j.jaut.2017.12.014_bib24) 2014; 9 Radon (10.1016/j.jaut.2017.12.014_bib23) 2017 Patrakka (10.1016/j.jaut.2017.12.014_bib17) 2002; 73 Prunotto (10.1016/j.jaut.2017.12.014_bib22) 2013; 82 Roopenian (10.1016/j.jaut.2017.12.014_bib30) 2007; 7 Zhou (10.1016/j.jaut.2017.12.014_bib26) 2015; 26 Azib (10.1016/j.jaut.2017.12.014_bib6) 2011; 26 Musante (10.1016/j.jaut.2017.12.014_bib16) 2005; 141 Schwartz (10.1016/j.jaut.2017.12.014_bib32) 2012; 82 Liu (10.1016/j.jaut.2017.12.014_bib2) 2014; 19 Iijima (10.1016/j.jaut.2017.12.014_bib7) 2014; 384 Colucci (10.1016/j.jaut.2017.12.014_bib8) 2016; 27 Rouillon (10.1016/j.jaut.2017.12.014_bib11) 2014; 24 Jamin (10.1016/j.jaut.2017.12.014_bib28) 2015; 182 |
References_xml | – volume: 44 start-page: 651 year: 1985 end-page: 653 ident: bib19 article-title: Immunoassay of the neuronal and neuroendocrine marker PGP 9.5 in human tissues publication-title: J. Neurochem. – volume: 182 start-page: 332 year: 2015 end-page: 345 ident: bib28 article-title: Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome publication-title: Clin. Exp. Immunol. – volume: 90 start-page: 327 year: 2010 end-page: 362 ident: bib18 article-title: UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein publication-title: Prog. Neurobiol. – volume: 108 start-page: 378 year: 1986 end-page: 382 ident: bib29 article-title: Role of respiratory viruses in exacerbations of primary nephrotic syndrome publication-title: J. Pediatr. – volume: 299 start-page: F845 year: 2010 end-page: F853 ident: bib13 article-title: Dose- and time-dependent glucocorticoid receptor signaling in podocytes publication-title: Am. J. Physiol. Ren. Physiol. – volume: 27 start-page: 1811 year: 2016 end-page: 1822 ident: bib8 article-title: B cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome publication-title: J. Am. Soc. Nephrol. – volume: 3 year: 2011 ident: bib15 article-title: Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis publication-title: Sci. Transl. Med. – volume: 7 start-page: 715 year: 2007 end-page: 725 ident: bib30 article-title: FcRn: the neonatal Fc receptor comes of age publication-title: Nat. Rev. Immunol. – volume: 359 start-page: 2492 year: 2008 end-page: 2494 ident: bib3 article-title: Proteinuria and immunity–an overstated relationship? publication-title: N. Engl. J. Med. – volume: 14 start-page: 931 year: 2008 end-page: 938 ident: bib14 article-title: The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A publication-title: Nat. Med. – volume: 13 start-page: 630 year: 2002 end-page: 638 ident: bib10 article-title: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression publication-title: J. Am. Soc. Nephrol. – volume: 73 start-page: 394 year: 2002 end-page: 403 ident: bib17 article-title: Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin publication-title: Transplantation – volume: 26 start-page: 927 year: 2011 end-page: 932 ident: bib6 article-title: Cyclophosphamide in steroid-dependent nephrotic syndrome publication-title: Pediatr. Nephrol. – volume: 384 start-page: 1273 year: 2014 end-page: 1281 ident: bib7 article-title: Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial publication-title: Lancet – volume: 41 start-page: 1155 year: 2003 end-page: 1162 ident: bib4 article-title: A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children publication-title: Am. J. Kidney Dis. – volume: 19 start-page: 392 year: 2014 end-page: 397 ident: bib2 article-title: Ultrastructural changes of podocyte foot processes during the remission phase of minimal change disease of human kidney publication-title: Nephrology – volume: 26 start-page: 677 year: 2015 end-page: 691 ident: bib26 article-title: Mutual antagonism of Wilms' tumor 1 and beta-catenin dictates podocyte health and disease publication-title: J. Am. Soc. Nephrol. – volume: 26 start-page: 1701 year: 2015 end-page: 1710 ident: bib5 article-title: HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome publication-title: J. Am. Soc. Nephrol. – volume: 12 start-page: 332 year: 2017 end-page: 345 ident: bib1 article-title: Minimal change disease publication-title: Clin. J. Am. Soc. Nephrol. – volume: 217 start-page: 452 year: 2009 end-page: 464 ident: bib20 article-title: A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies publication-title: J. Pathol. – volume: 82 start-page: 445 year: 2012 end-page: 453 ident: bib32 publication-title: Kidney Int. – volume: 29 start-page: 2325 year: 2014 end-page: 2331 ident: bib27 article-title: Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome publication-title: Pediatr. Nephrol. – volume: 141 start-page: 491 year: 2005 end-page: 499 ident: bib16 article-title: Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome publication-title: Clin. Exp. Immunol. – volume: 24 start-page: 563 year: 2014 end-page: 573 ident: bib11 article-title: Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy publication-title: Neuromuscul. Disord. – year: 2017 ident: bib23 article-title: Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney publication-title: Kidney Int. – volume: 217 start-page: 642 year: 2009 end-page: 653 ident: bib21 article-title: UCH-L1 expression of podocytes in diseased glomeruli and in vitro publication-title: J. Pathol. – volume: 10 year: 2016 ident: bib12 article-title: Interventions for idiopathic steroid-resistant nephrotic syndrome in children publication-title: Cochrane Database Syst. Rev. – volume: 9 year: 2014 ident: bib24 article-title: The expression and significance of neuronal iconic proteins in podocytes publication-title: PLos One – volume: 33 start-page: 4755 year: 2013 end-page: 4764 ident: bib25 article-title: Rac1 activation in podocytes induces rapid foot process effacement and proteinuria publication-title: Mol. Cell Biol. – volume: 16 start-page: 629 year: 2005 end-page: 637 ident: bib9 article-title: Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes publication-title: J. Am. Soc. Nephrol. – volume: 89 start-page: 178 year: 2009 end-page: 195 ident: bib31 article-title: Expression of galectin-1, a new component of slit diaphragm, is altered in minimal change nephrotic syndrome publication-title: Lab. Invest. – volume: 82 start-page: 193 year: 2013 end-page: 229 ident: bib22 article-title: Proteomic analysis of podocyte exosome-enriched fraction from normal human urine publication-title: J. Proteom. – volume: 73 start-page: 394 year: 2002 ident: 10.1016/j.jaut.2017.12.014_bib17 article-title: Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin publication-title: Transplantation doi: 10.1097/00007890-200202150-00013 – volume: 16 start-page: 629 year: 2005 ident: 10.1016/j.jaut.2017.12.014_bib9 article-title: Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2004030172 – volume: 44 start-page: 651 year: 1985 ident: 10.1016/j.jaut.2017.12.014_bib19 article-title: Immunoassay of the neuronal and neuroendocrine marker PGP 9.5 in human tissues publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.1985.tb05461.x – volume: 19 start-page: 392 year: 2014 ident: 10.1016/j.jaut.2017.12.014_bib2 article-title: Ultrastructural changes of podocyte foot processes during the remission phase of minimal change disease of human kidney publication-title: Nephrology doi: 10.1111/nep.12256 – volume: 9 year: 2014 ident: 10.1016/j.jaut.2017.12.014_bib24 article-title: The expression and significance of neuronal iconic proteins in podocytes publication-title: PLos One – volume: 359 start-page: 2492 year: 2008 ident: 10.1016/j.jaut.2017.12.014_bib3 article-title: Proteinuria and immunity–an overstated relationship? publication-title: N. Engl. J. Med. doi: 10.1056/NEJMcibr0806881 – volume: 7 start-page: 715 year: 2007 ident: 10.1016/j.jaut.2017.12.014_bib30 article-title: FcRn: the neonatal Fc receptor comes of age publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2155 – volume: 89 start-page: 178 year: 2009 ident: 10.1016/j.jaut.2017.12.014_bib31 article-title: Expression of galectin-1, a new component of slit diaphragm, is altered in minimal change nephrotic syndrome publication-title: Lab. Invest. doi: 10.1038/labinvest.2008.125 – year: 2017 ident: 10.1016/j.jaut.2017.12.014_bib23 article-title: Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney publication-title: Kidney Int. – volume: 26 start-page: 927 year: 2011 ident: 10.1016/j.jaut.2017.12.014_bib6 article-title: Cyclophosphamide in steroid-dependent nephrotic syndrome publication-title: Pediatr. Nephrol. doi: 10.1007/s00467-011-1830-0 – volume: 26 start-page: 1701 year: 2015 ident: 10.1016/j.jaut.2017.12.014_bib5 article-title: HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2014030247 – volume: 3 year: 2011 ident: 10.1016/j.jaut.2017.12.014_bib15 article-title: Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3002231 – volume: 29 start-page: 2325 year: 2014 ident: 10.1016/j.jaut.2017.12.014_bib27 article-title: Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome publication-title: Pediatr. Nephrol. doi: 10.1007/s00467-014-2860-1 – volume: 33 start-page: 4755 year: 2013 ident: 10.1016/j.jaut.2017.12.014_bib25 article-title: Rac1 activation in podocytes induces rapid foot process effacement and proteinuria publication-title: Mol. Cell Biol. doi: 10.1128/MCB.00730-13 – volume: 82 start-page: 193 year: 2013 ident: 10.1016/j.jaut.2017.12.014_bib22 article-title: Proteomic analysis of podocyte exosome-enriched fraction from normal human urine publication-title: J. Proteom. doi: 10.1016/j.jprot.2013.01.012 – volume: 82 start-page: 445 year: 2012 ident: 10.1016/j.jaut.2017.12.014_bib32 publication-title: Kidney Int. doi: 10.1038/ki.2012.169 – volume: 13 start-page: 630 year: 2002 ident: 10.1016/j.jaut.2017.12.014_bib10 article-title: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.V133630 – volume: 217 start-page: 642 year: 2009 ident: 10.1016/j.jaut.2017.12.014_bib21 article-title: UCH-L1 expression of podocytes in diseased glomeruli and in vitro publication-title: J. Pathol. doi: 10.1002/path.2511 – volume: 141 start-page: 491 year: 2005 ident: 10.1016/j.jaut.2017.12.014_bib16 article-title: Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome publication-title: Clin. Exp. Immunol. doi: 10.1111/j.1365-2249.2005.02862.x – volume: 217 start-page: 452 year: 2009 ident: 10.1016/j.jaut.2017.12.014_bib20 article-title: A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies publication-title: J. Pathol. doi: 10.1002/path.2446 – volume: 90 start-page: 327 year: 2010 ident: 10.1016/j.jaut.2017.12.014_bib18 article-title: UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein publication-title: Prog. Neurobiol. doi: 10.1016/j.pneurobio.2009.10.020 – volume: 41 start-page: 1155 year: 2003 ident: 10.1016/j.jaut.2017.12.014_bib4 article-title: A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children publication-title: Am. J. Kidney Dis. doi: 10.1016/S0272-6386(03)00346-9 – volume: 24 start-page: 563 year: 2014 ident: 10.1016/j.jaut.2017.12.014_bib11 article-title: Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy publication-title: Neuromuscul. Disord. doi: 10.1016/j.nmd.2014.03.012 – volume: 14 start-page: 931 year: 2008 ident: 10.1016/j.jaut.2017.12.014_bib14 article-title: The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A publication-title: Nat. Med. doi: 10.1038/nm.1857 – volume: 108 start-page: 378 year: 1986 ident: 10.1016/j.jaut.2017.12.014_bib29 article-title: Role of respiratory viruses in exacerbations of primary nephrotic syndrome publication-title: J. Pediatr. doi: 10.1016/S0022-3476(86)80876-9 – volume: 10 year: 2016 ident: 10.1016/j.jaut.2017.12.014_bib12 article-title: Interventions for idiopathic steroid-resistant nephrotic syndrome in children publication-title: Cochrane Database Syst. Rev. – volume: 299 start-page: F845 year: 2010 ident: 10.1016/j.jaut.2017.12.014_bib13 article-title: Dose- and time-dependent glucocorticoid receptor signaling in podocytes publication-title: Am. J. Physiol. Ren. Physiol. doi: 10.1152/ajprenal.00161.2010 – volume: 26 start-page: 677 year: 2015 ident: 10.1016/j.jaut.2017.12.014_bib26 article-title: Mutual antagonism of Wilms' tumor 1 and beta-catenin dictates podocyte health and disease publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2013101067 – volume: 384 start-page: 1273 year: 2014 ident: 10.1016/j.jaut.2017.12.014_bib7 article-title: Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(14)60541-9 – volume: 27 start-page: 1811 year: 2016 ident: 10.1016/j.jaut.2017.12.014_bib8 article-title: B cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2015050523 – volume: 182 start-page: 332 year: 2015 ident: 10.1016/j.jaut.2017.12.014_bib28 article-title: Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome publication-title: Clin. Exp. Immunol. doi: 10.1111/cei.12659 – volume: 12 start-page: 332 year: 2017 ident: 10.1016/j.jaut.2017.12.014_bib1 article-title: Minimal change disease publication-title: Clin. J. Am. Soc. Nephrol. doi: 10.2215/CJN.05000516 |
SSID | ssj0011555 |
Score | 2.4563038 |
Snippet | Idiopathic steroid sensitive nephrotic syndrome (INS), the most frequent childhood nephropathy, is thought to be mediated by a circulating soluble factor that... |
SourceID | hal proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 149 |
SubjectTerms | Adaptive immunology Adolescent Animals Autoantibodies - blood Cell Adhesion Cells, Cultured Child Disease Models, Animal Disease Progression Female Foot process effacement Human health and pathology Humans Immunoglobulin Immunoglobulin G - blood Immunoglobulin G - isolation & purification Immunology Life Sciences Male Mice Mice, Inbred BALB C Nephrotic Syndrome - immunology Pediatric nephrology Pediatrics Podocytes - physiology Proteinuria Proteinuria - immunology Ubiquitin Thiolesterase - genetics Ubiquitin Thiolesterase - immunology Urology and Nephrology |
Title | Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0896841117306844 https://dx.doi.org/10.1016/j.jaut.2017.12.014 https://www.ncbi.nlm.nih.gov/pubmed/29307588 https://www.proquest.com/docview/1989539482 https://univ-rennes.hal.science/hal-02445649 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEB96LYovovXr1JYovsl6l_24JI_H0bJq7Yse9C3k6-oW2T3aO6Ev4p_uzG52wYe20LfdkAlhZpKZSX6ZAfiAYuVCOJ9wYzFAcblNlOcu8dPMmozjGjEt2uJ0Vi7zL2fF2Q4s-rcwBKuMe3-3p7e7dWyZRG5O1lU1-T6VaiZzXKuopPiRj2AvRWuPEdje_PPX8nS4TECT2SIZsX9CBPHtTAfzuiCgCFpB0Z4K8vwm-zT6SUDJm7zQ1hodP4HH0Y1k826mT2En1PvwoCsseb0PD7_FK_Nn8He-3TTIvso2BBhk5txU6BKyNcaj7hrJ2XJRnnBmLgMzUVbBMzqfZZWvmrZksWN1QKk31L3PccDoGcz6ioasPcPQHpWEtWkfqnqLao1NjGrdP4fl8dGPRZnEsguJy2WxSRwliOJOZCovnOKZcGkIQSgvCi-FsCtkXAhuhpGZUkK1F5F5KlIbTOFXQWUvYLdu6vAKmJCFxJ7ScDPNg1-ZWSGERA8o5c5OlR0D75mtXcxJTqUxfukefHahSUCaBKR5qlFAY_g40Ky7jBy39s56Ger-rSnujhoNxq1UxUD1nzbeSfce1WSYFqXuLucnmtrQF6LMPeo3H8O7Xos0rmW6oDF1aLZXmvBrBbJdpmN42anXMBa6ZejdSfn6nlN7A4_wT3ZYzbewu7nchgP0pzb2EEaf_vDDuGr-AQEuHdI |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_alH28jK37aLZu08behklkS5H0GEKLu6Z5WQN9E7KkbC7DDm1S6Nv-9J1s2dCHdtA3I-uEuDvdnaSf7gC-oVipENYl1BS4QbGsSJSjNnHjrDAZxTViGrTFYpIv2Y8LfrEDs-4tTIBVRtvf2vTGWseWUeTmaF2Wo59jqSaS4VpFJcUPtgt7jKNNHsDe9OQ0X_SXCegyGyQj9k8CQXw708K8LgNQBL2gaE4FKbvPP-3-DkDJ-6LQxhsdv4QXMYwk03amr2DHV_vwpC0sebsPT8_ilflr-DvdbmpkX1nUATBIzC9TYkhI1rgftbdITpazfE6JufLERFl5R8L5LCldWTcliy2pPEq9Dt27HAckPINZX4chK0dwa49KQpq0D2W1RbXGJhJq3b-B5fHR-SxPYtmFxDLJN4kNCaKoFZli3CqaCZt674VygjspRLFCxnlvJ7gzU0qo5iKSpSItvOFu5VX2FgZVXfkDIEJyiT2loWbMvFuZCRdCYgSUUluMVTEE2jFb25iTPJTG-KM78NmlDgLSQUCaphoFNITvPc26zcjxYO-sk6Hu3pqiddToMB6k4j3VHW38L91XVJN-WiF1dz6d69CGsVDI3KNu6BC-dFqkcS2HCxpT-Xp7rQN-jSPbZTqEd6169WNhWIbRnZTvHzm1z_AsPz-b6_nJ4vQDPMc_ssVtHsJgc7X1HzG22hSf4tr5B7lGH7g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Autoantibodies+against+podocytic+UCHL1+are+associated+with+idiopathic+nephrotic+syndrome+relapses+and+induce+proteinuria+in+mice&rft.jtitle=Journal+of+autoimmunity&rft.au=Jamin%2C+Agn%C3%A8s&rft.au=Berthelot%2C+Laureline&rft.au=Couderc%2C+Anne&rft.au=Chemouny%2C+Jonathan+M&rft.date=2018-05-01&rft.eissn=1095-9157&rft.volume=89&rft.spage=149&rft_id=info:doi/10.1016%2Fj.jaut.2017.12.014&rft_id=info%3Apmid%2F29307588&rft.externalDocID=29307588 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0896-8411&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0896-8411&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0896-8411&client=summon |